APA

Lindgren L. M., Tingskov P. N., Justesen A. H., Nedergaard B. S., Olsen K. J., Andreasen L. V., Kromann I., Sørensen C., Dietrich J. & Thierry-Carstensen B. (20171215). First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccination at 3, 5, 12months and 5years of age. : Vaccine.

Chicago

Lindgren Line M, Tingskov Pernille N, Justesen Annette H, Nedergaard Bettina S, Olsen Klaus J, Andreasen Lars V, Kromann Ingrid, Sørensen Charlotte, Dietrich Jes and Thierry-Carstensen Birgit. 20171215. First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccination at 3, 5, 12months and 5years of age. : Vaccine.

Harvard

Lindgren L. M., Tingskov P. N., Justesen A. H., Nedergaard B. S., Olsen K. J., Andreasen L. V., Kromann I., Sørensen C., Dietrich J. and Thierry-Carstensen B. (20171215). First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccination at 3, 5, 12months and 5years of age. : Vaccine.

MLA

Lindgren Line M, Tingskov Pernille N, Justesen Annette H, Nedergaard Bettina S, Olsen Klaus J, Andreasen Lars V, Kromann Ingrid, Sørensen Charlotte, Dietrich Jes and Thierry-Carstensen Birgit. First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccination at 3, 5, 12months and 5years of age. : Vaccine. 20171215.